Evaluation of Prothrombin Time in Acute Acetaminophen Overdose treated by N-acetylcysteine
Authors
Abstract:
Background: Acetaminophen (N-Acetyl-p aminophenol; APAP) is one of the most common types of analgesics. It is also the most common xneobitic reported to poison centers. This study investigates if therapeutic doses of NAC can falsely increase coagulation tests, prothrombin time (PT) and bleeding time (BT). Methods: Thirty-six APAP poisoned patients whose acetaminophen serum concentration were in toxic zone in the Rummak-Matheiw graph were treated by NAC according to standard intravenous 21 hours protocol. Prothrombin time (PT) and bleeding time (BT) in all cases were measured before the start of the NAC and at the 8th and 16th hour of the treatment. Results: The mean age of the cases was 21.5 ± 5.12 years old. Among them, 31 cases (86%) were female. The mean dose of ingested APAP was 9.6 ±2.0 grams (7.8 – 16.1 g). Mean of SLA was 196.0±37.7. The means of BT were nor significantly different at all evolution times (2.6±0.64, 2.6±0.62 and 2.6± 0.6. The means of PT rose at 16th hour of NAC treatment in as compared 8th hour (16.1± 1.1 s 12.3±0.6 s, respectively) (P
similar resources
evaluation of prothrombin time in acute acetaminophen overdose treated by n-acetylcysteine
background: acetaminophen (n-acetyl-p aminophenol; apap) is one of the most common types of analgesics. it is also the most common xneobitic reported to poison centers. this study investigates if therapeutic doses of nac can falsely increase coagulation tests, prothrombin time (pt) and bleeding time (bt). methods: thirty-six apap poisoned patients whose acetaminophen serum concentration were...
full textN-Acetylcysteine Overdose After Acetaminophen Poisoning
N-acetylcysteine (NAC) is a drug used widely and effectively in oral and intravenous forms as a specific antidote for acetaminophen poisoning. In children considering the toxic dose of acetaminophen ingested by the patient and the body weight, the physician prescribes a specific dose of NAC. There is always a risk of iatrogenic overdose of NAC which can cause different mild to...
full textN-Acetylcysteine Overdose After Acetaminophen Poisoning
N-acetylcysteine (NAC) is a drug used widely and effectively in oral and intravenous forms as a specific antidote for acetaminophen poisoning. In children considering the toxic dose of acetaminophen ingested by the patient and the body weight, the physician prescribes a specific dose of NAC. There is always a risk of iatrogenic overdose of NAC which can cause different mild to...
full textN-acetylcysteine overdose after acetaminophen poisoning
N-acetylcysteine (NAC) is used widely and effectively in oral and intravenous forms as a specific antidote for acetaminophen poisoning. Here we report a rare case of iatrogenic NAC overdose following an error in preparation of the solution, and describe its clinical symptoms. Laboratory results and are presented and examined. A 23-year-old alert female patient weighing 65 kg presented to the em...
full textAcetaminophen overdose and N-acetylcysteine therapy.
Dear Editor, I read with interest the case report by Sule et al,1 published in the February 2006 issue of the journal. They reported a case of massive ingestion of paracetamol, successfully managed by a 3-day infusion of N-acetylcysteine. They concluded that a modified 3-day regime is safe and efficacious. Prolonged infusion of N-acetylcysteine for treatment of significant acetaminophen overdos...
full textN-acetylcysteine-induced headache in hospitalized patients with acute acetaminophen overdose.
Intravenous N-acetylcysteine (IV-NAC) is usually regarded as a safe antidote to acetaminophen overdose. However, during infusion of the loading dose, adverse drug reactions such as a headache may occur. The objectives of this study were to investigate the prevalence of headache in patients presenting to hospital after acetaminophen overdose and to determine which clinical findings are most pred...
full textMy Resources
Journal title
volume 5 issue 2
pages 46- 48
publication date 2016-06-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023